INSTITUTE FOR PROTEIN DESIGN
The mission of the University of Washington Institute for Protein Design is to design a new world of proteins to address 21st century challenges in medicine, energy and technology. The Institute for Protein Design was established in 2012, and is building on strengths within the University of Washington and Seattle more generally. Protein design requires high-level expertise and talent in computing and software, biochemistry, genome sciences, biological structure, pharmacology, immunology and ot... her basic science disciplines, as well as clinical medicine. They are marshaling deep institutional strengths in our faculty, scientific staff, postdoctoral fellows and graduate students, their partners from collaborating institutions, innovator networks, and from the computer and biotechnology industries — bringing extraordinary expertise to bear on a singular focus to advance the potential of protein design. Over the past 16 years, UW researchers have made significant progress in protein design and protein structure prediction, developing the world leading Rosetta software. During this period, UW scientists have developed methods for designing proteins with a wide range of new functions, including catalysts for chemical reactions, HIV and RSV vaccine candidates, and flu virus inhibitors. The IPD integrates these strengths in protein design with Seattle-area expertise in biochemistry, engineering, computer science and medicine, and leverages the exceptional Seattle strength in the software industry.
INSTITUTE FOR PROTEIN DESIGN
Industry:
Biotechnology Education
Founded:
2012-01-01
Status:
Active
Contact:
206-616-7542
Email Addresses:
[email protected]
Total Funding:
56.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache YouTube WordPress 6.0 COVID-19
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Investors List
The Audacious Project
The Audacious Project investment in Grant - Institute for Protein Design
Open Philanthropy Project
Open Philanthropy Project investment in Grant - Institute for Protein Design
Sahsen Ventures
Sahsen Ventures investment in Venture Round - Institute for Protein Design